Loading...

Cynata Therapeutics Limited

CYP.AX•ASX
Healthcare
Biotechnology
A$0.21
A$0.01(6.60%)

Cynata Therapeutics Limited (CYP.AX) Stock Chart & Performance Analysis

Explore Cynata Therapeutics Limited’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
2.63%
5-Day Change
11.43%
1-Month Change
-13.33%
3-Month Change
-15.22%
6-Month Change
-22.00%
Year-to-Date (YTD) Change
-18.75%
1-Year Change
5.41%
3-Year Change
-51.25%
5-Year Change
-75.55%
All-Time (Max) Change
-92.47%

Analyzing Cynata Therapeutics Limited (CYP.AX) Trends Across Multiple Time Frames

Cynata Therapeutics Limited Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Cynata Therapeutics Limited stock shows 2.63% 1-day change, indicating immediate volatility, while its 5-day change of 11.43% suggests a broader trend. Over a 1-month period, a -13.33% drop could signal a pullback, whereas a 3-month decline of -15.22% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -22.00% and a YTD drop of -18.75% might concern investors, but a 1-year gain of 5.41% and a 3-year drop of -51.25% could indicate resilience. The 5-year surge of -75.55% highlights weak historical growth, while the all-time return of -92.47% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;